Impact of Bacillus clausii supplementation on anti Helicobacter pylori therapy related side effects: A randomized double blind placebo controlled study

被引：0
|
作者：
Nista, EC
Cazzato, IA
Candelli, M
Franceschi, F
Fini, L
Cammarota, G
Gasbarrini, G
Gasbarrini, A
机构：
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(03)81825-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A361 / A361
页数：1
相关论文
共 50 条
  • [1] Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment:: randomized, double-blind, placebo controlled trial
    Nista, EC
    Candelli, M
    Cremonini, F
    Cazzato, IA
    Zocco, MA
    Franceschi, F
    Cammarota, G
    Gasbarrini, G
    Gasbarrini, A
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (10) : 1181 - 1188
  • [2] Effect of Bacillus clausii Capsules in Reducing Adverse Effects Associated with Helicobacter pylori Eradication Therapy: A Randomized, Double-Blind, Controlled Trial
    Manuel Plomer
    Marcos III Perez
    Dorothea Maren Greifenberg
    Infectious Diseases and Therapy, 2020, 9 : 867 - 878
  • [3] Impact or lactobacillus GG supplementation on anti-H-pylori therapy-related side effects:: A randomized placebo-controlled study.
    Cremonini, F
    Armuzzi, A
    Gabrielli, M
    Bartolozzi, F
    Candelli, M
    Canducci, F
    Ojetti, V
    Zocco, MA
    Santarelli, L
    Padalino, C
    Anti, M
    Gasbarrini, G
    Gasbarrini, A
    GUT, 2000, 47 : A103 - A103
  • [4] Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy -: a placebo-controlled, double-blind randomized pilot study
    Myllyluoma, E
    Veijola, L
    Ahlroos, T
    Tynkkynen, S
    Kankuri, E
    Vapaatalo, H
    Rautelin, H
    Korpela, R
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (10) : 1263 - 1272
  • [5] Effect of GutGard in the Management of Helicobacter pylori: A Randomized Double Blind Placebo Controlled Study
    Puram, Sreenivasulu
    Suh, Hyung Chae
    Kim, Seung Un
    Bethapudi, Bharathi
    Joseph, Joshua Allan
    Agarwal, Amit
    Kudiganti, Venkateswarlu
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 2013
  • [6] Inhibitory effects of β-caryophyllene on Helicobacter pylori infection: a randomized double-blind, placebo-controlled study
    Shim, H.
    Cho, J.
    Shin, C.
    Yoon, H.
    Park, Y.
    Kim, N.
    Lee, D.
    HELICOBACTER, 2019, 24
  • [7] Inhibitory effects of β-caryophyllene on Helicobacter pylori infection: a randomized double-blind, placebo-controlled study
    Shim, Hyun Ik
    Cho, Jae Ho
    Shin, Cheol Min
    Yoon, Hyuk
    Park, Young Soo
    Kim, Nayoung
    Lee, Dong Ho
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 324 - 324
  • [8] Probiotic supplementation with Lactobacillus plantarum and Pediococcus acidilactici for Helicobacter pylori therapy: A randomized, double-blind, placebo-controlled trial
    McNicholl, Adrian G.
    Molina-Infante, Javier
    Lucendo, Alfredo J.
    Luis Calleja, Jose
    Perez-Aisa, Angeles
    Modolell, Ines
    Aldeguer, Xavier
    Calafat, Margalida
    Comino, Luis
    Ramas, Mercedes
    Callejo, Angel
    Badiola, Carlos
    Serra, Jordi
    Gisbert, Javier P.
    HELICOBACTER, 2018, 23 (05)
  • [9] Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects:: A parallel group, triple blind, placebo-controlled study
    Cremonini, F
    Di Caro, S
    Covino, M
    Armuzzi, A
    Gabrielli, M
    Santarelli, L
    Nista, EC
    Cammarota, G
    Gasbarrini, G
    Gasbarrini, A
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (11): : 2744 - 2749
  • [10] Randomized, Double-blind, Placebo-controlled Trial: Effect of Lactobacillus GG Supplementation on Helicobacter Pylori Eradication Rates and Side Effects During Treatment in Children
    Szajewska, Hania
    Albrecht, Piotr
    Topczewska-Cabanek, Agnieszka
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2009, 48 (04): : 431 - 436
12345